[HTML][HTML] Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
J Liu, S Li, J Liu, B Liang, X Wang, H Wang, W Li… - …, 2020 - thelancet.com
Background The dynamic changes of lymphocyte subsets and cytokines profiles of patients
with novel coronavirus disease (COVID-19) and their correlation with the disease severity …
with novel coronavirus disease (COVID-19) and their correlation with the disease severity …
[HTML][HTML] SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
…, X Yang, W Li, B Zhu, W Zhou, H Wang, S Li… - Nature …, 2021 - nature.com
Long-term antibody responses and neutralizing activities in response to SARS-CoV-2
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …
[HTML][HTML] Declining levels of neutralizing antibodies against SARS-CoV-2 in convalescent COVID-19 patients one year post symptom onset
…, B Liang, Y Fang, S Lu, S Li, H Wang, H Li… - Frontiers in …, 2021 - frontiersin.org
Major advances have been made in understanding the dynamics of humoral immunity briefly
after the acute coronavirus disease 2019 (COVID-19). However, knowledge concerning …
after the acute coronavirus disease 2019 (COVID-19). However, knowledge concerning …
[HTML][HTML] ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019
Z Weng, Q Chen, S Li, H Li, Q Zhang, S Lu… - Journal of translational …, 2020 - Springer
Background Patients with severe Coronavirus Disease 2019 (COVID-19) will progress
rapidly to acute respiratory failure or death. We aimed to develop a quantitative tool for early …
rapidly to acute respiratory failure or death. We aimed to develop a quantitative tool for early …
[HTML][HTML] Characterization of SARS-CoV-2-Specific humoral and cellular immune responses induced by inactivated COVID-19 vaccines in a real-world setting
Z Li, T Xiang, B Liang, H Deng, H Wang… - Frontiers in …, 2021 - frontiersin.org
While the immunogenicity of inactivated vaccines against coronavirus disease 2019 (COVID‐19)
has been characterized in several well-conducted clinical trials, real-world evidence …
has been characterized in several well-conducted clinical trials, real-world evidence …
Timing of invasive mechanic ventilation in critically ill patients with coronavirus disease 2019
Q Zhang, J Shen, L Chen, S Li, W Zhang… - Journal of Trauma …, 2020 - journals.lww.com
Background Invasive mechanical ventilation (IMV) is a lifesaving strategy for critically ill
patients with coronavirus disease 2019 (COVID-19). We aim to report the case series of critical …
patients with coronavirus disease 2019 (COVID-19). We aim to report the case series of critical …
[HTML][HTML] No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate
the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with …
the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with …
[HTML][HTML] Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications
J Ye, M Lin, C Zhang, X Zhu, S Li, H Liu… - Biomedical …, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common types of cancer in the world, and
targeted therapy is frequently used in the clinical management of the disease. A complete and …
targeted therapy is frequently used in the clinical management of the disease. A complete and …
[HTML][HTML] Impact of hepatic encephalopathy on clinical characteristics and adverse outcomes in prospective and multicenter cohorts of patients with acute-on-chronic …
L Long, H Li, G Deng, X Wang, S Lu, B Li… - Frontiers in …, 2021 - frontiersin.org
Importance: Hepatic encephalopathy is a severe complication, and its contribution to clinical
adverse outcomes in patients with acute-on-chronic liver diseases from the East is unclear. …
adverse outcomes in patients with acute-on-chronic liver diseases from the East is unclear. …
[HTML][HTML] Baseline neutrophil-to-lymphocyte ratio is independently associated with 90-day transplant-free mortality in patients with cirrhosis
J Liu, H Li, J Xia, X Wang, Y Huang, B Li, Z Meng… - Frontiers in …, 2021 - frontiersin.org
Background: Patients with cirrhosis have an increased risk of short-term mortality, however,
few studies quantify the association between neutrophil-to-lymphocyte ratio (NLR) and 90-…
few studies quantify the association between neutrophil-to-lymphocyte ratio (NLR) and 90-…